A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)
Recruiting in Palo Alto (17 mi)
+10 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Endo Pharmaceuticals
No Placebo Group
Trial Summary
What is the purpose of this trial?
The purpose of this study is to observe and describe the effectiveness and local tolerability of intravesical treatment with valrubicin for non-muscle invasive bladder cancer (NMIBC) in a cohort of subjects treated under routine practice conditions.
Eligibility Criteria
Inclusion Criteria
Males and females 18 years of age and older
Diagnosed with NMIBC
Prescribed intravesical valrubicin to treat NMIBC
See 1 more
Treatment Details
Interventions
- Valrubicin (Anti-tumor antibiotic)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Delaware Valley UrologySewell, NJ
Kansas City Urology CareOverland Park, KS
Urologic Consultants of SE PABala-Cynwyd, PA
Delaware Valley UrologyVoorhees, NJ
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Endo PharmaceuticalsLead Sponsor